Recurrence and Survival after Gross Total Removal of Resectable Undifferentiated or Poorly Differentiated Thyroid Carcinoma

Thyroid

Volumn 26, Issue 9, 2016, Pages 1259-1268

  Lee, Doh Young ^a,b   Won, Jae Kyung ^a   Choi, Hoon Sung ^c,d   Park, Do Joon ^c   Jung, Kyeong Cheon ^a   Sung, Myung Whun ^a   Kim, Kwang Hyun ^a   Hah, J Hun ^a   Park, Young Joo ^c  

^a Seoul National University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Kangwon National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; RADIOACTIVE IODINE;

ADULT; AGED; ANAPLASTIC THYROID CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONFERENCE PAPER; DIFFERENTIATED THYROID CANCER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GOITER; HISTOPATHOLOGY; HUMAN; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NECK DISSECTION; OUTCOME ASSESSMENT; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SURVIVAL RATE; THYROIDECTOMY; TRACHEA TUMOR; TREATMENT RESPONSE; TUMOR INVASION; TUMOR VOLUME; UNDIFFERENTIATED CARCINOMA; MORTALITY; PATHOLOGY; THYROID CARCINOMA; THYROID TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; THYROID CARCINOMA, ANAPLASTIC; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84986216553     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2016.0147     Document Type: Conference Paper

References (27)

1. Are C, Shaha AR 2006 Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 13:453-464.
2. Akaishi J, Sugino K, Kitagawa W, Nagahama M, Kameyama K, Shimizu K, Ito K, Ito K 2011 Prognostic factors and treatment outcomes of 100 cases of anaplastic thyroid carcinoma. Thyroid 21:1183-1189.
3. Sanders EM Jr, LiVolsi VA, Brierley J, Shin J, Randolph GW 2007 An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934-945.
4. Kakudo K, Bai Y, Katayama S, Hirokawa M, Ito Y, Miyauchi A, Kuma K 2009 Classification of follicular cell tumors of the thyroid gland: analysis involving Japanese patients from one institute. Pathol Int 59:359-367.
5. Collini P, Mattavelli F, Pellegrinelli A, Barisella M, Ferrari A, Massimino M 2006 Papillary carcinoma of the thyroid gland of childhood and adolescence: morphologic subtypes, biologic behavior and prognosis: a clinicopathologic study of 42 sporadic cases treated at a single institution during a 30-year period. Am J Surg Pathol 30:1420-1426.
6. Sakamoto A, Kasai N, Sugano H 1983 Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849-1855.
7. Ibrahimpasic T, Ghossein R, Carlson DL, Nixon I, Palmer FL, Shaha AR, Patel SG, Tuttle RM, Shah JP, Ganly I 2014 Outcomes in patients with poorly differentiated thyroid carcinoma. J Clin Endocrinol Metab 99:1245-1252.
8. Han JM, Bae Kim W, Kim TY, Ryu JS, Gong G, Hong SJ, Kim JH, Oh YL, Jang HW, Kim SW, Chung JH, Shong YK 2012 Time trend in tumour size and characteristics of anaplastic thyroid carcinoma. Clin Endocrinol 77:459-464.
9. Haigh PI, Ituarte PH, Wu HS, Treseler PA, Posner MD, Quivey JM, Duh QY, Clark OH 2001 Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335-2342.
10. Lee DY, Won JK, Lee SH, Park DJ, Jung KC, Sung MW, Wu HG, Kim KH, Park YJ, Hah JH 2016 Changes of clinicopathologic characteristics and survival outcomes of anaplastic and poorly differentiated thyroid carcinoma. Thyroid 26:404-413.
11. Ebihara M, Kishimoto S, Hayashi R, Miyazaki M, Shinozaki T, Daiko H, Saikawa M, Sakuraba M, Miyamoto S 2011 Window resection of the trachea and secondary reconstruction for invasion by differentiated thyroid carcinoma. Auris Nasus Larynx 38:271-275.
12. Morisod B, Monnier P, Simon C, Sandu K 2014 Cricotracheal resection for laryngeal invasion by thyroid carcinoma: our experience. Eur Arch Otorhinolaryngol 271: 2261-2266.
13. Nishinari K, Krutman M, Valentim LA, Chulam TC, Yazbek G, Kowalski LP, Wolosker N 2014 Late surgical outcomes of carotid resection and saphenous vein graft revascularization in patients with advanced head and neck squamous cell carcinoma. Ann Vasc Surg 28:1878-1884.
14. Brignardello E, Palestini N, Felicetti F, Castiglione A, Piovesan A, Gallo M, Freddi M, Ricardi U, Gasparri G, Ciccone G, Arvat E, Boccuzzi G 2014 Early surgery and survival of patients with anaplastic thyroid carcinoma: analysis of a case series referred to a single institution between 1999 and 2012. Thyroid 24:1600-1606.
15. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J 2007 Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256-1264.
16. Derbel O, Limem S, Ségura-Ferlay C, Lifante JC, Carrie C, Peix JL, Borson-Chazot F, Bournaud C, Droz JP, de la Fouchardière C 2011 Results of combined treatment of anaplastic thyroid carcinoma (ATC). BMC Cancer 11:469.
17. Tan RK, Finley RK 3rd, Driscoll D, Bakamjian V, Hicks WL Jr, Shedd DP 1995 Anaplastic carcinoma of the thyroid: a 24-year experience. Head Neck 17:41-47; discussion 47-48.
18. McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS, Thompson GB, van Heerden JA, Goellner JR 2001 Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery 130:1028-1034.
19. Mohebati A, Dilorenzo M, Palmer F, Patel SG, Pfister D, Lee N, Tuttle RM, Shaha AR, Shah JP, Ganly I 2014 Anaplastic thyroid carcinoma: a 25-year single-institution experience. Ann Surg Oncol 21:1665-1670.
20. Sugitani I, Miyauchi A, Sugino K, Okamoto T, Yoshida A, Suzuki S 2012 Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients. World J Surg 36:1247-1254.
21. Sun C, Li Q, Hu Z, He J, Li C, Li G, Tao X, Yang A 2013 Treatment and prognosis of anaplastic thyroid carcinoma: experience from a single institution in China. PLOS ONE 8:e80011.
22. Sugitani I, Hasegawa Y, Sugasawa M, Tori M, Higashiyama T, Miyazaki M, Hosoi H, Orita Y, Kitano H 2014 Super-radical surgery for anaplastic thyroid carcinoma: a large cohort study using the anaplastic thyroid carcinoma research consortium of Japan database. Head Neck 36:328-333.
23. He X, Li D, Hu C, Wang Z, Ying H, Wu Y 2014 Outcome after intensity modulated radiotherapy for anaplastic thyroid carcinoma. BMC Cancer 14:235.
24. Pierie JP, Muzikansky A, Gaz RD, Faquin WC, Ott MJ 2002 The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57-64.
25. Besic N, Hocevar M, Zgajnar J, Pogacnik A, Grazio-Frkovic S, Auersperg M 2005 Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients. Langenbecks Arch Surg 390:203-208.
26. Voutilainen PE, Multanen M, Haapiainen RK, Leppäniemi AK, Sivula AH 1999 Anaplastic thyroid carcinoma survival. World J Surg 23:975-978; discussion 978-979.
27. Ibrahimpasic T, Ghossein R, Carlson DL, Chernichenko N, Nixon I, Palmer FL, Lee NY, Shaha AR, Patel SG, Tuttle RM, Balm AJ, Shah JP, Ganly I 2013 Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid 23:997-1002.